|Bid||247.00 x 900|
|Ask||261.12 x 800|
|Day's range||258.33 - 266.50|
|52-week range||165.52 - 272.25|
|Beta (5Y monthly)||1.45|
|PE ratio (TTM)||124.61|
|Earnings date||08 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||300.22|
DocuSign's (DOCU) third-quarter fiscal 2022 earnings and revenues increase year over year.
RESEARCH TRIANGLE PARK, N.C., December 02, 2021--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is launching new Research Nursing and Phlebotomy services. These new services offer patients participating in clinical trials access to a global network of high-quality, credentialed professionals that provide compassionate protocol-required care within their own homes.
The Zacks Technology Services industry is likely to benefit from COVID-19-driven dependency on technology, increased digitization and adoption of the multi-cloud model. IQV, STX and BCOR are well positioned to witness the demand surge.